Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.
p27kip1 is a cyclin-dependent kinase inhibitor that regulates progression from G1 into S phase. Aberrations in cell cycle control are often observed in tumors and might even be necessary in tumor development. Recent reports showed that low p27kip1 expression is associated with poor prognosis in seve...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Academy of Medical Sciences
2000
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054650/ |